PRP vs PRP+IVC for Severe nPDR
- Conditions
- Severe Nonproliferative Diabetic RetinopathyDiabete MellitusDiabetic Retinopathy
- Interventions
- Procedure: Panretinal coagulation
- First Posted Date
- 2019-03-05
- Last Posted Date
- 2019-03-05
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT03863535
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS
- Conditions
- P53 MutationMyeloid MalignancyMDSAml
- Interventions
- First Posted Date
- 2019-02-26
- Last Posted Date
- 2022-11-04
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 5
- Registration Number
- NCT03855371
- Locations
- 🇨🇳
Hematological department, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai, Shanghai, China
Study Evaluating the Safety and Efficacy of C-CHOP in Untreated Subjects With Angioimmunoblastic T Cell Lymphoma
- Conditions
- Angioimmunoblastic T-cell Lymphoma
- Interventions
- First Posted Date
- 2019-02-25
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 23
- Registration Number
- NCT03853044
- Locations
- 🇨🇳
Ruijin hospital, Shanghai, Shanghai, China
Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment
- Conditions
- Breast Cancer
- Interventions
- Radiation: Conventional radiotherapyRadiation: Hypofractionated radiotherapy
- First Posted Date
- 2019-02-04
- Last Posted Date
- 2022-06-02
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 801
- Registration Number
- NCT03829553
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
Microbial Diversity of Pancreatic Diseases
- Conditions
- Pancreatic CancerPancreatic Disease
- First Posted Date
- 2019-01-18
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 330
- Registration Number
- NCT03809247
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy
- Conditions
- Pulmonary MetastasesApatinibOsteosarcoma
- Interventions
- Drug: GD regimen
- First Posted Date
- 2018-11-15
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 43
- Registration Number
- NCT03742193
- Locations
- 🇨🇳
Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Multicenter Epidemiologic Study of Severe Community Acquired Pneumonia in China
- Conditions
- Community-acquired Pneumonia
- First Posted Date
- 2018-11-02
- Last Posted Date
- 2018-11-02
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT03728816
- Locations
- 🇨🇳
Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
R2 in the Treatment of Follicular Lymphoma
- First Posted Date
- 2018-10-23
- Last Posted Date
- 2019-07-08
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 115
- Registration Number
- NCT03715309
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
Lenalidomide Based Immunotherapy in the Treatment of DLBCL
- Conditions
- Diffuse Large B Cell Lymphoma
- First Posted Date
- 2018-10-23
- Last Posted Date
- 2019-07-08
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT03715296
- Locations
- 🇨🇳
Ruijin hospital, Shanghai, Shanghai, China
Study Of Bacterial/Fungal Infections in Hospitalized Patients With Liver Cirrhosis in China
- Conditions
- Cirrhosis
- First Posted Date
- 2018-09-19
- Last Posted Date
- 2019-11-19
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 1232
- Registration Number
- NCT03676777
- Locations
- 🇨🇳
Second Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China
🇨🇳First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
🇨🇳Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian, China